Clinical Trial Update: Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma

View source ↗

Summary

A completed clinical trial update describing the intake conditions for sunitinib in patients with renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Cancer Foundation, China | Conditions: Renal Cell Carcinoma | Status: COMPLETED